AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 78 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 3.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,000 | -40.0% | 1,525 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $5,000 | +25.0% | 1,525 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $4,000 | 0.0% | 1,525 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $4,000 | -63.6% | 1,525 | 0.0% | 0.00% | -71.4% |
| Q1 2015 | $11,000 | +120.0% | 1,525 | 0.0% | 0.01% | +133.3% |
| Q4 2014 | $5,000 | 0.0% | 1,525 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $5,000 | -61.5% | 1,525 | 0.0% | 0.00% | -62.5% |
| Q2 2014 | $13,000 | +30.0% | 1,525 | 0.0% | 0.01% | +14.3% |
| Q1 2014 | $10,000 | -9.1% | 1,525 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $11,000 | 0.0% | 1,525 | 0.0% | 0.01% | -12.5% |
| Q3 2013 | $11,000 | +22.2% | 1,525 | 0.0% | 0.01% | +14.3% |
| Q2 2013 | $9,000 | +28.6% | 1,525 | 0.0% | 0.01% | -12.5% |
| Q1 2013 | $7,000 | – | 1,525 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
| CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
| Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
| Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
| COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
| Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |